Brilliant Violet 421™ anti-mouse CD25 Antibody

Pricing & Availability
Clone
PC61 (See other available formats)
Regulatory Status
RUO
Other Names
IL-2Rα, Ly-43, p55, Tac
Isotype
Rat IgG1, λ
Ave. Rating
Submit a Review
Product Citations
publications
PC61_BV421_1_040411
C57BL/6 mouse splenocytes were stained with CD4 FITC and CD25 (clone PC61) Brilliant Violet 421™ (top) or rat IgG1, κ Brilliant Violet 421™ isotype control (bottom).
  • PC61_BV421_1_040411
    C57BL/6 mouse splenocytes were stained with CD4 FITC and CD25 (clone PC61) Brilliant Violet 421™ (top) or rat IgG1, κ Brilliant Violet 421™ isotype control (bottom).
  • PC61_BV421_2_040411
Compare all formats See Brilliant Violet 421™ spectral data
Cat # Size Price Quantity Check Availability Save
102033 125 µL £128
Check Availability


Need larger quantities of this item?
Request Bulk Quote
102043 50 µg £166
Check Availability


Need larger quantities of this item?
Request Bulk Quote
102034 500 µL £271
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD25 is a 55 kD glycoprotein also known as the low affinity IL-2Rα, Ly-43, p55, or Tac. It is expressed on activated T and B cells, thymocyte subsets, pre-B cells, and T regulatory cells. In association with CD122 (IL-2Rβ) and CD132 (common γ chain), CD25 forms the high affinity signaling IL-2 receptor.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
IL-2-dependent cytolytic mouse T-cell clone B6.1
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).
Preparation
The antibody was purified by affinity chromatography and conjugated with Brilliant Violet 421™ under optimal conditions.
Concentration
µg sizes: 0.2 mg/mL
µL sizes: lot-specific (to obtain lot-specific concentration, please enter the lot number in our Concentration and Expiration Lookup or Certificate of Analysis online tools.)
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For immunofluorescent staining using the µg size, the suggested use of this reagent is ≤0.125 µg per million cells in 100 µl volume. For immunofluorescent staining using µl sizes, the suggested use of this reagent is 5 µl per million cells in 100 µl staining volume or 5 µl per 100 µl of whole blood. It is recommended that the reagent be titrated for optimal performance for each application.

Brilliant Violet 421™ excites at 405 nm and emits at 421 nm. The standard bandpass filter 450/50 nm is recommended for detection. Brilliant Violet 421™ is a trademark of Sirigen Group Ltd.


Learn more about Brilliant Violet™.

This product is subject to proprietary rights of Sirigen Inc. and is made and sold under license from Sirigen Inc. The purchase of this product conveys to the buyer a non-transferable right to use the purchased product for research purposes only. This product may not be resold or incorporated in any manner into another product for resale. Any use for therapeutics or diagnostics is strictly prohibited. This product is covered by U.S. Patent(s), pending patent applications and foreign equivalents.
Excitation Laser
Violet Laser (405 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation1,2, in vitro blocking of IL-2 binding to low- and high-affinity receptors1-4, growth inhibition of IL-2-dependent T-cell lines1-4, in vivo depletion of CD25+CD4+ Treg cells5-8,10, and immunohistochemical staining of acetone-fixed frozen sections2. PC61 antibody recognizes a different epitope than 3C7 antibody (Cat. No. 101902). For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 102040) with endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered. 

Application References

(PubMed link indicates BioLegend citation)
  1. Lowenthal JW, et al. 1985. Nature 315:669. (IP, Block)
  2. Ceredig R, et al. 1985. Nature 314:98. (IP, IHC, Block)
  3. Lowenthal JW, et al. 1985. J. Immunol. 135:3988. (Block)
  4. Moreau JL, et al. 1987. Eur. J. Immunol. 17:929. (Block)
  5. Takahashi T, et al. 2000. J. Exp. Med. 192:303. (Deplete)
  6. Onizuka S, et al. 1999. Cancer Res. 59:3128. (Deplete)
  7. Lei TC, et al. 2005. Blood 105:4865. (Deplete)
  8. Pasare C, et al. 2004. Immunity 21:733. (Deplete)
  9. León-Ponte M, et al. 2007. Blood 109:3139.
  10. Cao OW, et al. 2007. Blood doi:10.1182/blood-2007-02-073304. (Deplete)
  11. Benson MJ, et al. 2007. J. Exp. Med. doi:10.1084/jem.20070719.
  12. Liu F, et al. 2011. Arch Toxicol. 85:1383. PubMed
  13. Anguela XM, et al. 2013. Diabetes. 62:551. PubMed
Product Citations
  1. Ramakrishna C, et al. 2019. Nat Commun. 10:2153. PubMed
  2. Haratani K, et al. 2019. J Clin Invest. 130:374. PubMed
  3. Wang D, et al. 2018. Immunity. 48:659. PubMed
  4. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  5. Pokrovskii M, et al. 2020. EMBO J. 39:e104159. PubMed
  6. Trott DW, et al. 2021. Geroscience. 43:1331. PubMed
  7. Sugimoto C, et al. 2022. Elife. 11:. PubMed
  8. Ayasoufi K, et al. 2020. Brain. 3629:143. PubMed
  9. Alissafi T, et al. 2020. Cell Metabolism. 32(4):591-604.e7. PubMed
  10. Miyazaki M et al. 2017. Immunity. 46(5):818-834 . PubMed
  11. Ramos CV, et al. 2020. Cell Reports. 32(3):107910. PubMed
  12. Yin Q, et al. 2021. Proc Natl Acad Sci U S A. 118: . PubMed
  13. Friedman DJ, et al. 2021. Cancer Immunol Res. 9:952. PubMed
  14. Takeshita Y, et al. 2021. Neurol Neuroimmunol Neuroinflamm. 8:. PubMed
  15. Vogel A, et al. 2022. STAR Protoc. 3:101653. PubMed
  16. Galle-Treger L, et al. 2016. Nat Commun. 7:13202. PubMed
  17. Efremova M, et al. 2018. Nat Commun. 9:32. PubMed
  18. Klepsch V, et al. 2018. Nat Commun. 9:1538. PubMed
  19. de Picciotto S, et al. 2022. Nat Commun. 13:3866. PubMed
  20. Compeer EB, et al. 2018. Nat Commun. 9:1597. PubMed
  21. Zhu S, et al. 2022. EBioMedicine. 80:104060. PubMed
  22. Fan MY et al. 2018. Cell reports. 25(5):1204-1213 . PubMed
  23. Coley WD et al. 2018. F1000Research. 2018 Mar 14 [revised 2018 Jan 1] 0.5125. PubMed
  24. Damgaard RB et al. 2016. Cell. 166(5):1215-1230 . PubMed
  25. Vogel A, et al. 2022. Cell Rep. 38:110420. PubMed
  26. Knox T, et al. 2019. Sci Rep. 9:6136. PubMed
  27. Field CS, et al. 2020. Cell Metab. 31:422. PubMed
  28. Miao Y et al. 2019. Cell. 177(5):1172-1186 . PubMed
  29. Schick V, et al. 2014. Gut. 63:1469. PubMed
RRID
AB_10895908 (BioLegend Cat. No. 102033)
AB_2562611 (BioLegend Cat. No. 102043)
AB_11203373 (BioLegend Cat. No. 102034)

Antigen Details

Structure
Forms high affinity IL-2R with IL-2Rβ (CD122) and IL-2Rγ (CD132), 55 kD
Distribution

Activated T cells and B cells, thymocyte subset, pre-B cells, T regulatory cells

Function
IL-2 receptor
Ligand/Receptor
IL-2
Cell Type
B cells, T cells, Thymocytes, Tregs
Biology Area
Immunology
Molecular Family
CD Molecules, Cytokine/Chemokine Receptors
Antigen References
  1. Taniguchi T, et al. 1993. Cell 73:5-8.
  2. Waldmann TA. 1991. J Biol Chem. 266:2681-4.
  3. Read S, et al. 2000. J Exp Med. 192:295-302.
  4. Lowenthal JW, et al. 1985. J Immunol. 135:3988-94.
Gene ID
16184 View all products for this Gene ID
UniProt
View information about CD25 on UniProt.org

Related FAQs

What is the F/P ratio range of our BV421™ format antibody reagents?

It is lot-specific. On average it ranges between 2-4.

Go To Top Version: 2    Revision Date: 10/21/2013

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

  • APC anti-mouse CD25

  • Biotin anti-mouse CD25

  • FITC anti-mouse CD25

  • PE anti-mouse CD25

  • PE/Cyanine5 anti-mouse CD25

  • Purified anti-mouse CD25

  • PE/Cyanine7 anti-mouse CD25

  • Alexa Fluor® 488 anti-mouse CD25

  • Alexa Fluor® 647 anti-mouse CD25

  • Pacific Blue™ anti-mouse CD25

  • Alexa Fluor® 700 anti-mouse CD25

  • APC/Cyanine7 anti-mouse CD25

  • PerCP/Cyanine5.5 anti-mouse CD25

  • PerCP anti-mouse CD25

  • Brilliant Violet 421™ anti-mouse CD25

  • Brilliant Violet 605™ anti-mouse CD25

  • Brilliant Violet 650™ anti-mouse CD25

  • Ultra-LEAF™ Purified anti-mouse CD25

  • Brilliant Violet 510™ anti-mouse CD25

  • PE/Dazzle™ 594 anti-mouse CD25

  • Brilliant Violet 711™ anti-mouse CD25

  • Brilliant Violet 785™ anti-mouse CD25

  • Alexa Fluor® 594 anti-mouse CD25

  • APC/Fire™ 750 anti-mouse CD25

  • TotalSeq™-A0097 anti-mouse CD25

  • KIRAVIA Blue 520™ anti-mouse CD25

  • TotalSeq™-B0097 anti-mouse CD25

  • TotalSeq™-C0097 anti-mouse CD25

  • Spark NIR™ 685 anti-mouse CD25 Antibody

  • PE/Fire™ 640 anti-mouse CD25

  • Spark YG™ 581 anti-mouse CD25

  • APC/Fire™ 810 anti-mouse CD25

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account